ATE362387T1 - Verwendung eines mutterkrautextrakts zur regulierung der hautalterung - Google Patents

Verwendung eines mutterkrautextrakts zur regulierung der hautalterung

Info

Publication number
ATE362387T1
ATE362387T1 AT02733853T AT02733853T ATE362387T1 AT E362387 T1 ATE362387 T1 AT E362387T1 AT 02733853 T AT02733853 T AT 02733853T AT 02733853 T AT02733853 T AT 02733853T AT E362387 T1 ATE362387 T1 AT E362387T1
Authority
AT
Austria
Prior art keywords
extract
feverweed
skin aging
regulate skin
regulating
Prior art date
Application number
AT02733853T
Other languages
English (en)
Inventor
Katharine Martin
Claude Saliou
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Application granted granted Critical
Publication of ATE362387T1 publication Critical patent/ATE362387T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
AT02733853T 2001-03-16 2002-03-14 Verwendung eines mutterkrautextrakts zur regulierung der hautalterung ATE362387T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27630401P 2001-03-16 2001-03-16

Publications (1)

Publication Number Publication Date
ATE362387T1 true ATE362387T1 (de) 2007-06-15

Family

ID=23056101

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02733853T ATE362387T1 (de) 2001-03-16 2002-03-14 Verwendung eines mutterkrautextrakts zur regulierung der hautalterung

Country Status (12)

Country Link
US (2) US7547456B2 (de)
EP (1) EP1367993B1 (de)
JP (2) JP2004524335A (de)
CN (1) CN100539984C (de)
AT (1) ATE362387T1 (de)
AU (1) AU2002305054B2 (de)
BR (2) BR0208123A (de)
CA (1) CA2441025C (de)
DE (1) DE60220145T2 (de)
ES (1) ES2286254T3 (de)
MX (1) MXPA03008391A (de)
WO (1) WO2002074280A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
CN100539984C (zh) 2001-03-16 2009-09-16 强生消费者公司 含有小白菊提取物的组合物及其用途
EP1543823A1 (de) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Gingkoextrakt enthaltende kosmetische Zubereitungen zur Verbesserung des Hautglanzes
EP1543822A1 (de) * 2003-12-19 2005-06-22 Johnson & Johnson Consumer France SAS Soja enthaltende kosmetische Zubereitungen zur Verbesserung des Hautglanzes
JP4880233B2 (ja) * 2004-03-17 2012-02-22 株式会社コーセー 抗皮膚障害剤、及びこれを含有する皮膚外用剤
DK2233127T3 (da) 2004-03-17 2020-08-24 Stada Arzneimittel Ag Anvendelse af antioxidanter til fremstilling af en farmaceutisk eller kosmetisk sammensætning for at beskytte huden mod skader som følge af infrarød stråling
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US20070059268A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions, methods and kits for treating allergic dermatitis of skin
US7547434B2 (en) 2005-09-09 2009-06-16 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for mitigating skin irritation
US20070059390A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions for inhibiting or reducing inflammation of skin
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient
RU2423974C2 (ru) * 2005-10-20 2011-07-20 ЭПИФАРМ ГмбХ Лечение и профилактика доброкачественных пигментных пятен (невусов) с помощью артемизинина и его производных
NZ595600A (en) 2006-02-21 2013-03-28 Akzo Nobel Surface Chemistry Llc Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production
WO2009040782A2 (en) * 2007-09-28 2009-04-02 Royal College Of Surgeons In Ireland A method of assessing colorectal cancer status in an individual
US8080265B2 (en) * 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
US8906432B2 (en) * 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
US20110081430A1 (en) * 2009-10-02 2011-04-07 Simarna Kaur COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
US8084504B2 (en) 2009-10-02 2011-12-27 Johnson & Johnson Consumer Companies, Inc. High-clarity aqueous concentrates of 4-hexylresorcinol
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
CN102198163B (zh) * 2011-05-27 2014-10-22 江西海富生物工程有限公司 一种小白菊提取物的制备方法
WO2013092699A2 (en) * 2011-12-22 2013-06-27 Akzo Nobel Chemicals International B.V. Bioactive compositions having skin anti-aging activity
WO2013092698A2 (en) 2011-12-22 2013-06-27 Akzo Nobel Chemicals International B.V. Bioactive compositions having hair anti aging activity
US8790720B2 (en) * 2011-12-22 2014-07-29 The Procter & Gamble Company Compositions and methods for treating skin
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
CN110101652A (zh) * 2019-06-14 2019-08-09 芳香世家化妆品(广州)有限公司 一种修护精华露
CN110642867B (zh) * 2019-06-21 2020-07-21 上海澄穆生物科技有限公司 8-乙烯亚胺-小白菊内酯盐酸盐及其制备方法与应用
KR102615332B1 (ko) * 2023-09-13 2023-12-20 (주)케이에이치케미칼 피버퓨 추출물을 포함하는 화장료 조성물

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE198501C (de)
US3755560A (en) * 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
GB1541463A (en) * 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4268629A (en) * 1980-03-03 1981-05-19 Monsanto Company Production of angiogenic factor by cell culture
US4421769A (en) * 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US4960764A (en) * 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
ATE112156T1 (de) 1989-10-27 1994-10-15 Richardson Vicks Inc Lichtschutzmittel mit verbesserter aktivität.
US5268176A (en) * 1991-07-22 1993-12-07 Avon Products, Inc. Method and compositions for the non-invasive treatment of telangiectasia
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
FR2695931B1 (fr) 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
JP3485377B2 (ja) * 1995-02-21 2004-01-13 日清オイリオ株式会社 紫外線吸収剤
JP3597245B2 (ja) 1995-02-23 2004-12-02 花王株式会社 シワ形成抑制剤
WO1996031194A2 (en) 1995-04-03 1996-10-10 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids and liposomes
US5550148A (en) * 1995-06-07 1996-08-27 Zymogenetics, Inc. PAF synthesis modulators
FR2736263B1 (fr) * 1995-07-07 1997-09-26 C3D Sarl Composition dermocosmetique depigmentante et son utilisation
US6337320B1 (en) * 1996-10-11 2002-01-08 Thione International, Inc. Reparatives for ultraviolet radiation skin damage
US6103218A (en) * 1997-04-23 2000-08-15 Brucker; Donald Therapeutic nasal spray administered composition containing feverfew
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
JPH1135444A (ja) 1997-07-18 1999-02-09 Nikko Chem Kk 新規化粧料
EP1011630B2 (de) * 1997-09-12 2008-10-15 The Procter & Gamble Company Hautreinigungs- und konditionierungsartikel für haut und haar
FR2783169B1 (fr) * 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
JP2000143485A (ja) 1998-11-06 2000-05-23 Sony Cp Laboratories Inc 皮膚細胞老化抑制組成物
WO2000074699A1 (en) * 1999-06-03 2000-12-14 Johnson & Johnson Consumer France Sas Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
CN100539984C (zh) 2001-03-16 2009-09-16 强生消费者公司 含有小白菊提取物的组合物及其用途
US20030077343A1 (en) 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof

Also Published As

Publication number Publication date
EP1367993A1 (de) 2003-12-10
JP5005644B2 (ja) 2012-08-22
BRPI0208123B1 (pt) 2020-11-10
CA2441025A1 (en) 2002-09-26
ES2286254T3 (es) 2007-12-01
US7547456B2 (en) 2009-06-16
AU2002305054B2 (en) 2006-09-07
EP1367993B1 (de) 2007-05-16
CN100539984C (zh) 2009-09-16
US20060165646A1 (en) 2006-07-27
BR0208123A (pt) 2004-03-09
JP2004524335A (ja) 2004-08-12
DE60220145T2 (de) 2008-02-14
WO2002074280A1 (en) 2002-09-26
CN1498101A (zh) 2004-05-19
JP2009029827A (ja) 2009-02-12
US20020182166A1 (en) 2002-12-05
CA2441025C (en) 2011-08-16
MXPA03008391A (es) 2004-11-12
DE60220145D1 (de) 2007-06-28

Similar Documents

Publication Publication Date Title
ATE362387T1 (de) Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
WO2002080876A3 (fr) Utilisation d'un extrait d'algue phaeodactylum pour favoriser l'activite du proteasome des cellules de la peau
TW200512007A (en) Cosmetic compositions containing fullerene clusters
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
SI2298338T1 (sl) Laktoferinski sestavki in postopki za zdravljenjekožnih ran
DE60124989D1 (de) Verwendung eines Haarkosmetischen Mittels zur Reparatur oder zur Vorbeugung von porösen Haar
ATE380054T1 (de) Topisches mittel zur dermatologischen verwendung enthaltend 4-hydroxyphenyl-alpha-d-glucopyranosid
ATE309775T1 (de) Die verwendung von prostaglandin f analoga zur herstellung von zusammensetzungen für die behandlung von haarausfall.
ATE168555T1 (de) Kosmetisches oder pharmazeutisches präparat zur topischer verwendung gegen freien radikale
BRPI0409660A (pt) método de medida da eficiência de um programa de tratamento de pele
ATE242638T1 (de) Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen
DE60230961D1 (de) Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
MXPA05000073A (es) Uso de isoflavonas para preparar composiciones topicas para promover el adelgazamiento, y metodo de tratamiento cosmetico relacionado.
RU2003117446A (ru) Косметический способ лечения кожи
PL340467A1 (en) Application of mithrazapin in treating apnoea dissomnia
DE69110234T2 (de) Verwendung von Vitamin D Verbindungen zur Herstellung einer kosmetischen Zusammensetzung und Anwendung dieser zur Verbesserung der Hautbeschaffenheit.
WO2002056859A3 (en) Composition containing hedychium extract and use thereof
ATE486567T1 (de) Orale zusammensetzung mit einer ersten zusammensetzung (a) und einer zweiten zusammensetzung (b) zur verwendung als gemische zur getrennten oder aufeinanderfolgenden verwendung in der kosmetischen behandlung des menschlichen körpers
DE60128009D1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ID27755A (id) Komposisi parfum
EP0945127A3 (de) Verwendung von Acyl-Carnitin
ATE327726T1 (de) Verwendung von alkoholdehydrogenase-inhibitoren in der kosmetischen behandlung von keratinmaterial
DE60210313D1 (de) Verwendung von dattelkern-extrakt zur minderung der anzeichen der hautalterung
ATE419825T1 (de) Partikuläre farbzusammensetzung und ihre anwendung in körperpflegeprodukten
DE602004016292D1 (de) Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties